| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Inventories | NaN | NaN | 16,101 |
| Accrued liabilities, pension and other liabilities | NaN | NaN | -23,774 |
| Income taxes payable | NaN | NaN | 5,069 |
| Accounts receivables, net | NaN | NaN | 13,809 |
| Accounts payable | NaN | NaN | 14,021 |
| Income from continuing operations | 20,632 | 15,822 | 57,726 |
| Gain on sale of real estate and equipment | NaN | NaN | -102 |
| (gain) loss on sale of business | NaN | NaN | 0 |
| Depreciation and amortization | 9,984 | 9,817 | 35,438 |
| Deferred income taxes | NaN | NaN | -9,666 |
| Stock-based compensation | 3,064 | 1,774 | 8,691 |
| Prepaid expenses and other assets | NaN | NaN | -19,959 |
| Non-cash portion of restructuring charge | 0 | 149 | 10 |
| Contributions to defined benefit plans | -1,511 | -1,285 | -7,796 |
| Life insurance benefit | NaN | NaN | 223 |
| Changes in operating assets and liabilities, net | 11,466 | 9,469 | NaN |
| Net cash provided by operating activities - continuing operations | 20,703 | 16,808 | 69,647 |
| Net cash used in operating activities - discontinued operations | -145 | 18 | -52 |
| Net cash provided by operating activities | 20,558 | 16,826 | 69,595 |
| Proceeds from sale of real estate and equipment | NaN | NaN | 438 |
| Proceeds withdrawn from life insurance policies | NaN | NaN | 3,494 |
| Proceeds from sale of business | NaN | NaN | 0 |
| Expenditures for property, plant, and equipment | 7,664 | 6,420 | 28,343 |
| Expenditures for executive life insurance policies | NaN | NaN | 132 |
| Expenditures for acquisitions, net of cash acquired | 0 | NaN | 478,890 |
| Other investing activity | 64 | -59 | 0 |
| Net cash provided by (used for) investing activities from continuing operations | NaN | NaN | -503,433 |
| Net cash provided by investing activities from discontinued operations | NaN | NaN | 0 |
| Activity under share-based payment plans | NaN | NaN | 2,226 |
| Net cash used in investing activities | -7,728 | -6,361 | -503,433 |
| Proceeds from borrowings | 8,000 | NaN | 792,313 |
| Payments of debt | 18,000 | 8,000 | 389,109 |
| Contingent consideration payment | 0 | 330 | 0 |
| Activity under share-based payment plans | 388 | 1,140 | NaN |
| Purchases of treasury stock and other | 56 | 3,742 | 9,906 |
| Distributions to non-controlling interests | 873 | 725 | NaN |
| Cash dividends paid | 4,094 | 3,836 | 15,033 |
| Net cash (used in) provided by financing activities | -14,635 | -15,493 | 380,491 |
| Effect of exchange rate changes on cash and cash equivalents | 150 | -861 | 3,686 |
| Net change in cash and cash equivalents | -1,655 | -5,889 | -49,661 |
| Cash and cash equivalents at beginning of period | 98,653 | 104,542 | NaN |
| Cash and cash equivalents at end of period | 96,998 | 98,653 | NaN |
STANDEX INTERNATIONAL CORP DE (SXI)
STANDEX INTERNATIONAL CORP DE (SXI)